Zoll Medical, Myant ink next-gen LifeVest dev deal

Asahi Kasei Group company Zoll Medical said it inked an exclusive strategic multi-year deal with advanced manufacturing company Myant to develop technologies for future versions of Zoll’s LifeVest wearable defibrillator.

The company’s LifeVest is designed to be worn by patients at risk of sudden cardiac death to monitor the heart continuously for abnormal heart arrhythmias and responds automatically, Zoll said. The system consists of an electrode belt and chest garment and a wrist-worn monitor.

Read the whole story on our sister site, Medical Design & Outsourcing

The post Zoll Medical, Myant ink next-gen LifeVest dev deal appeared first on MassDevice.

from MassDevice http://ift.tt/2nJjiPd